JMP starts American Medical Systems at market outperform

JMP Securities analyst Robert C. Faulkner began coverage of American Medical Systems Holdings Inc. with a market outperform rating and $23.50 price target. The analyst expects the Laserscope acquisition to be favorable but is caution on early signs of success. Still, according to Faulkner, Laserscope can cement American Medical Systems' leadership in the surgical urology space. Shares of the Minnetonka, Minn.-based medical device company were up 25 cents, or 1.45%, at $17.48. (Nasdaq: AMMD)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.